October 12, 2011
Asahi Kasei Pharma announced on October 11 that it will start clinical trials next year for a transdermal absorption formulation of human parathyroid hormone (HPTH), by applying the transdermal microprojection drug delivery system developed by Zosano Pharma of the US...read more